北米のヘルスケアIT市場規模、シェア、動向、2030年までの予測

北米のヘルスケアIT市場は、2026年の2,709億4,000万米ドルから2031年には5,290億6,000万米ドルに成長し、年平均成長率（CAGR）は14.3%に達するとMarketsandMarketsでは予測しています。

相互運用可能なヘルスケアインフラ、AIを活用した臨床ソリューション、クラウドベースのヘルスケアプラットフォームへの投資増加が、米国とカナダにおける市場成長を加速させています。医療従事者の燃え尽き症候群の軽減、ケア連携の改善、レガシーITインフラの近代化に医療提供者が注力していることも、市場拡大を後押ししています。米国保健情報技術国家調整官室（ONC）によると、米国の非連邦系急性期病院の96%以上が認証済みの電子カルテシステムを導入しており、相互運用性、分析機能、ワークフロー最適化ソリューションに対する強い需要を生み出しています。

調査概要

本レポートは、北米のヘルスケアIT市場を分析しています。ソリューション＆サービス、コンポーネント、エンドユーザー、国別といった様々な市場セグメントに基づき、市場規模と将来の成長可能性を推定することを目的としています。また、主要企業の競合分析に加え、企業概要、製品・サービス、最近の動向、主要な市場戦略についても解説しています。

本レポートを購入する理由

本レポートは、既存企業および新規参入企業・中小企業が市場の動向を把握し、より大きな市場シェアを獲得するのに役立ちます。本レポートを購入した企業は、以下の戦略を一つ以上活用することで、市場における地位を強化することができます。

本レポートでは、以下の点について考察します。

北米の医療IT市場の成長に影響を与える主要な推進要因（医療費高騰抑制の必要性の高まり、ONCおよびCMSのイニシアチブに基づく相互運用性と医療データ交換に対する強力な連邦政府の支援）、阻害要因（中小規模の医療機関における導入・統合コストの高さ）、機会（米国の外来診療センターにおける医療ITソリューションの導入拡大、北米における遠隔患者モニタリングおよび在宅医療プラットフォームの普及拡大）、そして課題（米国の医療機関および支払システムに対するサイバー攻撃の増加）の分析。

• 製品開発／イノベーション：北米ヘルスケアIT市場における今後のテクノロジー、研究開発活動、製品・サービスの発売に関する詳細な分析
• 市場開発：有望な新興市場、製品・サービス、テクノロジー、エンドユーザー、国に関する包括的な情報
• 市場の多様化：北米ヘルスケアIT市場における製品ポートフォリオ、未開拓地域、最新動向、投資に関する詳細な情報
• 競合分析：北米ヘルスケアIT市場における主要企業（Optum, Inc.（米国）、Cognizant（米国）、Koninklijke Philips N.V.（オランダ）、Oracle（米国）、GE Healthcare（米国）、Dell Inc.（米国）、Wipro（インド）、eClinicalWorks（米国）、SAS Institute Inc.（米国）、Inovalon（米国）など）の市場シェア、成長戦略、製品ラインナップ、能力に関する詳細な分析

Report Description

The North America healthcare IT market is projected to reach USD 529.06 billion by 2031 from USD 270.94 billion in 2026, at a CAGR of 14.3%. Rising investments in interoperable healthcare infrastructure, AI-enabled clinical solutions, and cloud-based healthcare platforms are accelerating market growth across the US and Canada. Increasing provider focus on reducing clinician burnout, improving care coordination, and modernizing legacy IT infrastructure is further supporting market expansion. According to the Office of the National Coordinator for Health Information Technology (ONC), over 96% of non-federal acute care hospitals in the US have adopted certified electronic health record systems, creating strong demand for interoperability, analytics, and workflow optimization solutions.

“Clinical healthcare IT solutions segment to witness the fastest growth within healthcare provider solutions market.”

Based on healthcare provider solutions, the clinical healthcare IT solutions segment is expected to register the highest growth during the forecast period. Rising adoption of clinical decision support systems, telehealth platforms, electronic health records, and AI-assisted clinical documentation tools is accelerating segment growth across hospitals and ambulatory care settings. According to the American Hospital Association, telehealth utilization remains significantly higher than pre-pandemic levels as healthcare systems continue integrating virtual care into long-term care delivery models. Healthcare providers are increasingly investing in integrated clinical workflows to improve physician productivity, reduce medical errors, and enhance patient outcomes. In addition, growing demand for remote patient monitoring and AI-enabled diagnostics is strengthening the adoption of advanced clinical healthcare IT platforms across large healthcare networks.

“Population health management solutions accounted for the largest share within the healthcare payer solutions market in 2025.”

Based on healthcare payer solutions, population health management solutions accounted for the largest share of the market in 2025. Payer organizations across North America are increasingly focusing on value-based care delivery, chronic disease management, and predictive risk assessment to improve healthcare outcomes while controlling overall healthcare expenditure. According to the Centers for Disease Control and Prevention (CDC), nearly 6 in 10 adults in the US live with at least one chronic disease, increasing the need for analytics-driven population health management platforms. These solutions enable payers to identify high-risk populations, improve care coordination, optimize reimbursement strategies, and support preventive healthcare initiatives. Increasing payer-provider collaboration and rising adoption of data-driven care management models are further strengthening demand for population health management solutions across the region.

“US market projected to register the highest growth during the forecast period.”

Based on country, the US is expected to register the highest growth rate in the North America healthcare IT market during the forecast period. The country continues to witness strong investments in healthcare interoperability, AI-enabled healthcare automation, cybersecurity modernization, and cloud-based digital health infrastructure. Federal initiatives supporting electronic health information exchange and digital care transformation are further accelerating healthcare IT adoption across hospitals, payer organizations, and physician networks. In addition, according to the Healthcare Information and Management Systems Society (HIMSS), healthcare organizations across the US are significantly increasing investments in AI-enabled workflow automation and cybersecurity technologies to address operational inefficiencies and rising cyber threats. The growing adoption of digital therapeutics, enterprise analytics platforms, and connected care infrastructure is expected to further strengthen market growth across the US healthcare ecosystem.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.

The breakdown of primary participants is as mentioned below:

• By Company Type – Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
• By Designation – C-level Executives: 40%, Directors: 35%, and Others: 25%
• By Country – US: 75%, Canada: 25%

Note: Other designations include sales, marketing, and product managers.

Tiers are defined based on a company’s total revenue as of 24: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

Key Players in the North America Healthcare IT Market

The key players functioning in the North America healthcare IT market include Optum, Inc. (US), Cognizant (US), Koninklijke Philips N.V. (Netherlands), Dell Inc. (US), GE Healthcare (US), Oracle (US), Epic Systems Corporation. (US), Veradigm LLC (US), SAS Institute Inc. (US), Nuance Communications, Inc. (US), Wipro (India), eClinicalWorks (US), Inovalon (US), Infor (US), and Conifer Health Solutions, LLC (US), among others.

Research Coverage

The report analyzes the North America healthcare IT market. It aims to estimate the market size and future growth potential of various market segments based on Solution & Service, component, end user, and country. The report also provides a competitive analysis of the key players in this market, along with their company profiles, offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will help established firms and new entrants/smaller firms gauge the market’s pulse, which, in turn, would help them garner a larger market share. Firms purchasing the report could use one or more of the strategies listed below to strengthen their market positions.

This report provides insights into:

Analysis of key drivers (Growing need to reduce escalating healthcare costs, Strong federal support for interoperability and healthcare data exchange under ONC and CMS initiatives), restraints (High implementation and integration costs for small and mid-sized healthcare organizations), opportunities (Increasing deployment of healthcare IT solutions across outpatient and ambulatory care centers in the US, Growing adoption of remote patient monitoring and home-based care platforms across North America), and challenges (Rising cybersecurity attacks targeting US healthcare organizations and payer systems) influencing the growth of the North America healthcare IT market

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the North America healthcare IT market
• Market Development: Comprehensive information on the lucrative emerging markets, products & services, technologies, end users, and countries
• Market Diversification: Exhaustive information about the product portfolios, untapped geographies, recent developments, and investments in the North America healthcare IT market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players such as Optum, Inc. (US), Cognizant (US), Koninklijke Philips N.V. (Netherlands), Oracle (US), GE Healthcare (US), Dell Inc. (US), Wipro (India), eClinicalWorks (US), SAS Institute Inc. (US), and Inovalon (US), among others in the North America healthcare IT market

Table of Contents

1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.3 STUDY SCOPE 34
1.3.1 MARKET SEGMENTATION 34
1.3.2 INCLUSIONS & EXCLUSIONS 35
1.4 YEARS CONSIDERED 35
1.5 CURRENCY CONSIDERED 35
1.6 LIMITATIONS 36
1.7 STAKEHOLDERS 36
2 EXECUTIVE SUMMARY 38
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 38
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 40
2.3 DISRUPTIVE TRENDS SHAPING MARKET 41
2.4 HIGH-GROWTH SEGMENTS 42
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 43
3 PREMIUM INSIGHTS 45
3.1 NORTH AMERICA HEALTHCARE IT MARKET OVERVIEW 45
3.2 US HEALTHCARE IT MARKET, BY COMPONENT AND SOLUTION & SERVICE 46
3.3 NORTH AMERICA HEALTHCARE IT MARKET: GEOGRAPHIC SNAPSHOT 46
4 MARKET OVERVIEW 47
4.1 INTRODUCTION 47
4.2 MARKET DYNAMICS 47
4.2.1 DRIVERS 48
4.2.1.1 Strong federal support for interoperability and healthcare data exchange under ONC and CMS initiatives 48
4.2.1.2 Rising use of big data and healthcare analytics platforms across provider and payer organizations 49
4.2.1.3 High return on investment associated with healthcare IT and workflow automation solutions 50
4.2.1.4 Growing adoption of telehealth, mHealth, and remote patient monitoring solutions across North America 51
4.2.1.5 Growing need to reduce escalating healthcare costs 52
4.2.2 RESTRAINTS 52
4.2.2.1 Increasing complexity of regulatory compliance and healthcare data management requirements 52
4.2.2.2 High implementation and integration costs for small and mid-sized healthcare organizations across North America 53
4.2.2.3 Resistance to digital workflow transition among traditional healthcare settings 54
4.2.3 OPPORTUNITIES 54
4.2.3.1 Increasing deployment of healthcare IT solutions across outpatient and ambulatory care centers in US 54
4.2.3.2 Rising adoption of cloud-based EHR and interoperable healthcare platforms 55
4.2.3.3 Growing adoption of remote patient monitoring and home-based care platforms across North America 57
4.2.4 CHALLENGES 57
4.2.4.1 Rising cybersecurity attacks targeting US healthcare organizations and payer systems 57
4.2.4.2 Integration challenges between legacy hospital systems and cloud-based healthcare platforms 60
4.2.4.3 Shortage of skilled healthcare IT and cybersecurity professionals across region 61
4.3 UNMET NEEDS AND WHITE SPACES 62
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 63
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 64
5 INDUSTRY TRENDS 65
5.1 PORTER’S FIVE FORCES ANALYSIS 65
5.2 MACROECONOMIC INDICATORS 68
5.2.1 INTRODUCTION 68
5.2.2 GDP TRENDS AND FORECAST 68
5.2.3 TRENDS IN NORTH AMERICA HEALTHCARE IT INDUSTRY 69
5.3 VALUE CHAIN ANALYSIS 69
5.4 ECOSYSTEM ANALYSIS 72
5.5 PRICING ANALYSIS 73
5.5.1 INDICATIVE PRICE FOR HEALTHCARE IT SOLUTIONS,
BY SOLUTION & SERVICE, 2025 73
5.5.1.1 Indicative pricing for clinical decision support systems, by product 74
5.5.1.2 Indicative price of HCIT integration solutions, by type 74
5.5.1.3 Indicative price of laboratory information systems (LIS) 76
5.5.1.4 Indicative price of patient registry software 77
5.5.1.5 Indicative price of healthcare analytics solutions, by component 78
5.5.2 INDICATIVE PRICE FOR HEALTHCARE ANALYTICS SOLUTIONS, BY REGION, 2025 78
5.6 KEY CONFERENCES & EVENTS, 2026–2027 79
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 80
5.8 INVESTMENT & FUNDING SCENARIO 81
5.9 CASE STUDY ANALYSIS 82

5.10 NORTH AMERICA HEALTHCARE IT MARKET – IMPACT OF 2025 US TARIFF 85
5.10.1 INTRODUCTION 85
5.10.2 KEY TARIFF RATES 86
5.10.3 PRICE IMPACT ANALYSIS 86
5.10.4 IMPACT ON COUNTRY 87
5.10.4.1 US 87
5.10.4.2 Canada 87
5.10.5 IMPACT ON END USERS 88
5.10.5.1 Healthcare providers 88
5.10.5.2 Payers 88
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTION 89
6.1 KEY EMERGING TECHNOLOGIES 89
6.1.1 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 89
6.1.2 CLOUD COMPUTING 90
6.1.3 BIG DATA & ANALYTICS 90
6.1.4 INTEROPERABILITY & HEALTHCARE INFORMATION EXCHANGE PLATFORM 91
6.1.5 APP-ENABLED PATIENT PORTALS 91
6.2 COMPLEMENTARY TECHNOLOGIES 92
6.2.1 INTERNET OF MEDICAL THINGS (IOMT) 92
6.2.2 BLOCKCHAIN 92
6.2.3 SMART HOSPITAL INFRASTRUCTURE 93
6.2.4 ROBOTIC PROCESS AUTOMATION 93
6.3 ADJACENT TECHNOLOGIES 94
6.3.1 VIRTUAL REALITY (VR) & AUGMENTED REALITY (AR) 94
6.3.2 EDGE COMPUTING 94
6.3.3 MEDICAL ROBOTICS 95
6.4 TECHNOLOGY/PRODUCT ROADMAP 95
6.5 PATENT ANALYSIS 96
6.5.1 PATENT PUBLICATION TRENDS FOR NORTH AMERICA HEALTHCARE IT MARKET 96
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 97
6.6 FUTURE APPLICATIONS 100
6.6.1 AI-DRIVEN CLINICAL DECISION SUPPORT 100
6.6.2 PRECISION MEDICINE & GENOMICS INTEGRATION 100
6.6.3 REMOTE PATIENT MONITORING & VIRTUAL CARE 101

6.7 IMPACT OF GEN AI IN NORTH AMERICA HEALTHCARE IT MARKET 101
6.7.1 MARKET POTENTIAL OF AI/GEN AI IN NORTH AMERICA HEALTHCARE IT MARKET 102
6.7.2 KEY USE CASES OF GEN AI IN HEALTHCARE IT SOLUTIONS 103
6.7.2.1 AI-driven clinical summarization and interoperability intelligence at InterSystems HealthShare 103
6.7.2.2 AI-Powered Health Information Exchange (HIE) and Clinical Data Summarization 104
6.7.2.3 Digital Patient Journey Transformation and Digital Front Door Expansion 104
6.7.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 105
6.7.3.1 Revenue cycle management market 105
6.7.3.2 Telehealth and telemedicine market 106
6.7.3.3 Healthcare fraud analytics market 106
6.7.4 USERS READINESS AND IMPACT ASSESSMENT 106
6.7.4.1 User readiness 106
6.7.4.1.1 Payers 106
6.7.4.1.2 Providers 106
6.7.4.2 Impact assessment 107
6.7.4.2.1 User A: Payers 107
6.7.4.2.1.1 Implementation 107
6.7.4.2.1.2 Impact 107
6.7.4.2.2 User B: Providers 107
6.7.4.2.2.1 Implementation 107
6.7.4.2.2.2 Impact 108
7 REGULATORY LANDSCAPE 109
7.1 REGIONAL REGULATIONS AND COMPLIANCE 109
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110
7.1.2 REGULATORY FRAMEWORK 111
7.1.2.1 North America 111
7.1.3 INDUSTRY STANDARDS 111
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 113
8.1 INTRODUCTION 113
8.2 DECISION-MAKING PROCESS 113
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 113
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 114
8.3.2 BUYING CRITERIA 115
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 116
8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 117
8.5.1 UNMET NEEDS 117
8.5.2 END USER EXPECTATIONS 118
8.6 MARKET PROFITABILITY 119
9 NORTH AMERICA HEALTHCARE IT MARKET, BY COMPONENT 120
9.1 INTRODUCTION 121
9.2 SERVICES 121
9.2.1 RISING REGULATORY AND CYBERSECURITY PRESSURES TO DRIVE DEMAND FOR MANAGED HEALTHCARE IT SERVICES 121
9.3 SOFTWARE 122
9.3.1 CLOUD-BASED SAAS PLATFORMS AND AI-ENABLED APPLICATIONS ARE ACCELERATING SOFTWARE SEGMENT GROWTH 122
9.4 HARDWARE 123
9.4.1 EXPANSION OF CONNECTED CARE INFRASTRUCTURE, SUSTAINING HEALTHCARE HARDWARE INVESTMENTS 123
10 HEALTHCARE IT MARKET, BY SOLUTIONS AND SERVICES 125
10.1 INTRODUCTION 126
10.2 HEALTHCARE PROVIDER SOLUTIONS 126
10.2.1 CLINICAL HCIT SOLUTIONS 127
10.2.1.1 Electronic health records 129
10.2.1.1.1 Cloud-based EHR deployment fueling market growth 129
10.2.1.2 Population health management 130
10.2.1.2.1 Value-based care transition and chronic disease burden are driving PHM platform adoption 130
10.2.1.3 Specialty information management 131
10.2.1.3.1 Oncology information system 132
10.2.1.3.1.1 Advanced cancer data management boosting OIS demand 132
10.2.1.3.2 Cardiology information system 133
10.2.1.3.2.1 Integrated Cardiology Data Management Driving CVIS Growth 133
10.2.1.3.3 Other information systems 134
10.2.1.3.3.1 Specialty information management systems are expanding across high-complexity clinical service lines 134
10.2.1.4 PACS & VNA 135
10.2.1.4.1 Driving healthcare data interoperability through VNA deployment 135
10.2.1.5 Mhealth application 136
10.2.1.5.1 Expanding digital health engagement through smartphone-based care solutions 136
10.2.1.6 HCIT integration 137
10.2.1.6.1 Advancing API-driven data exchange across North American healthcare networks 137
10.2.1.7 Telehealth solution 138
10.2.1.7.1 Driving telehealth growth through favorable CMS reimbursement policies 138

10.2.1.8 Medical image analysis 139
10.2.1.8.1 Accelerating adoption of FDA-cleared AI imaging solutions 139
10.2.1.9 Laboratory information systems 139
10.2.1.9.1 Laboratory automation imperatives and FHIR-based results 139
10.2.1.10 Practice management systems 140
10.2.1.10.1 Ambulatory care growth and revenue cycle automation are driving practice management platform modernization 140
10.2.1.11 Clinical decision support system 141
10.2.1.11.1 AI-powered evidence integration and patient safety mandates accelerate adoption 141
10.2.1.12 Eprescribing solution 142
10.2.1.12.1 Driving electronic prescription adoption across North American healthcare systems 142
10.2.1.13 Radiology information systems 143
10.2.1.13.1 Transforming radiology workflows with integrated RIS solutions 143
10.2.1.14 Computerized physician order entry 144
10.2.1.14.1 Patient safety imperatives and EHR integration sustaining CPOE adoption 144
10.2.1.15 Patient registry software 144
10.2.1.15.1 Accelerating precision medicine initiatives through advanced patient registry platforms 144
10.2.1.16 Infection surveillance 145
10.2.1.16.1 Driving adoption of real-time infection tracking and reporting solutions 145
10.2.1.17 Radiation dose management 146
10.2.1.17.1 Driving healthcare adoption of radiation exposure monitoring technologies 146
10.2.2 NON-CLINICAL HEALTHCARE IT SOLUTIONS 147
10.2.2.1 Healthcare asset management 149
10.2.2.1.1 Real-time location systems and IoT integration are transforming hospital asset visibility and utilization 149
10.2.2.2 Revenue cycle management 150
10.2.2.2.1 Front-end RCM solutions 151
10.2.2.2.1.1 Enhancing patient access and financial workflows through intelligent RCM solutions 151
10.2.2.2.2 Mid-RCM solutions 152
10.2.2.2.2.1 Accelerating mid-revenue cycle transformation through AI-powered coding automation 152
10.2.2.2.3 Back-end-RCM solutions 153
10.2.2.2.3.1 Optimizing financial outcomes through automated back-end RCM platforms 153
10.2.2.3 Healthcare analytics 154
10.2.2.3.1 Clinical analytics 155
10.2.2.3.1.1 Accelerating clinical decision-making through advanced analytics platforms 155
10.2.2.3.2 Financial analytics 156
10.2.2.3.2.1 Leveraging predictive analytics to strengthen revenue cycle operations 156
10.2.2.3.3 Operational and administrative analytics 157
10.2.2.3.3.1 Driving workforce efficiency through AI-enabled operational analytics 157
10.2.2.4 Customer relationship management 158
10.2.2.4.1 Patient engagement mandates and consumer-centric care models are driving healthcare CRM adoption 158
10.2.2.5 Pharmacy information systems 159
10.2.2.5.1 Improving medication management through integrated pharmacy information platforms 159
10.2.2.6 Healthcare interoperability 160
10.2.2.6.1 FHIR standardization and regulatory interoperability mandates are accelerating market growth 160
10.2.2.7 Healthcare quality management 160
10.2.2.7.1 Enhancing patient outcomes through advanced quality management solutions 160
10.2.2.8 Supply chain management 161
10.2.2.8.1 Procurement management 162
10.2.2.8.1.1 Driving cost optimization through intelligent procurement management systems 162
10.2.2.8.2 Inventory management 163
10.2.2.8.2.1 Real-time inventory visibility and intelligent replenishment are driving healthcare inventory modernization 163
10.2.2.9 Medication management 164
10.2.2.9.1 Electronic medication administration 165
10.2.2.9.1.1 Driving medication administration accuracy through digital eMAR platforms 165
10.2.2.9.2 Barcode medication administration systems 166
10.2.2.9.2.1 Advancing clinical workflow efficiency through eMAR implementation 166
10.2.2.9.3 Medication inventory management systems 167
10.2.2.9.3.1 Enhancing medication traceability through barcode-based inventory management systems 167
10.2.2.9.4 Medication assurance systems 167
10.2.2.9.4.1 Advancing patient safety through end-to-end barcode medication verification 167
10.2.2.10 Workforce management 168
10.2.2.10.1 Driving operational excellence through workforce optimization solutions 168
10.2.2.11 Healthcare information exchange 169
10.2.2.11.1 Enhancing care coordination through secure health data exchange solutions 169

10.2.2.12 Medical document management 170
10.2.2.12.1 Driving operational efficiency through digital medical document management 170
10.3 HEALTHCARE PAYER SOLUTIONS 170
10.3.1 CLAIMS MANAGEMENT 171
10.3.1.1 Regulatory mandates and claims automation to drive modernization of claims management solutions 171
10.3.2 POPULATION HEALTH MANAGEMENT 172
10.3.2.1 Population health management adoption accelerates with value-based care growth 172
10.3.3 PHARMACY AUDIT & ANALYSIS 173
10.3.3.1 Regulatory scrutiny to accelerate pharmacy audit solutions 173
10.3.4 CUSTOMER RELATIONSHIP MANAGEMENT 174
10.3.4.1 Medicare advantage programs accelerate CRM adoption 174
10.3.5 FRAUD ANALYTICS SOLUTIONS 175
10.3.5.1 Healthcare fraud prevention to accelerate analytics investments 175
10.3.6 PROVIDER NETWORK MANAGEMENT 176
10.3.6.1 Growing regulatory oversight supports network management solutions 176
10.4 HCIT OUTSOURCING SERVICES 177
10.4.1 IT INFRASTRUCTURE MANAGEMENT 178
10.4.1.1 Cybersecurity and cloud migration fuel market growth 178
10.4.2 PAYER HCIT OUTSOURCING SERVICES 179
10.4.2.1 Claims management 180
10.4.2.1.1 Revenue cycle optimization to accelerate claims outsourcing 180
10.4.2.2 Provider network management 181
10.4.2.2.1 Growing administrative complexity supports outsourcing 181
10.4.2.3 Billing & accounts management 181
10.4.2.3.1 Administrative cost reduction of fuel billing outsourcing 181
10.4.2.4 Fraud analytics 182
10.4.2.4.1 Growing claims volumes to support fraud analytics services 182
10.4.2.5 Other payer HCIT outsourcing services 183
10.4.2.5.1 Regulatory reporting complexity is expanding payer HCIT outsourcing demand 183
10.4.3 PROVIDER HCIT OUTSOURCING SERVICES 184
10.4.3.1 Revenue cycle management 185
10.4.3.1.1 Reimbursement optimization driving RCM service adoption 185
10.4.3.2 Medical documents management 185
10.4.3.2.1 AI-powered document processing is accelerating outsourcing demand 185
10.4.3.3 Laboratory information management 186
10.4.3.3.1 Interoperability requirements supporting LIS outsourcing growth 186
10.4.3.4 Other provider HCIT outsourcing services 187
10.4.3.4.1 Operational flexibility and specialized digital support are driving demand 187
10.4.4 OPERATIONAL HCIT OUTSOURCING SERVICES 187
10.4.4.1 Supply chain management 189
10.4.4.1.1 Inventory optimization to support supply chain outsourcing 189
10.4.4.2 Business process management 189
10.4.4.2.1 Administrative burden reduction to fuel BPM outsourcing 189
10.4.4.3 Other operational HCIT outsourcing services 190
10.4.4.3.1 Cybersecurity resilience and enterprise operations modernization to drive demand 190
11 NORTH AMERICA HEALTHCARE IT MARKET, BY END USER 192
11.1 INTRODUCTION 193
11.2 HEALTHCARE PROVIDERS 193
11.2.1 HOSPITALS 194
11.2.1.1 Enterprise EHR and AI integration accelerating hospital IT transformation 194
11.2.2 AMBULATORY CARE CENTERS (OUTPATIENT SETTING) 195
11.2.2.1 Digital transformation and outpatient care expansion fuel market growth 195
11.2.3 HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES 196
11.2.3.1 Assisted living facilities are increasingly investing in digital healthcare technologies 196
11.2.4 DIAGNOSTIC & IMAGING CENTERS 197
11.2.4.1 Enterprise imaging modernization and interoperability expansion fuel imaging healthcare IT market 197
11.2.5 PHARMACIES 198
11.2.5.1 AI-enabled pharmacy automation and e-prescribing solutions are accelerating healthcare IT adoption 198
11.3 HEALTHCARE PAYERS 199
11.3.1 PUBLIC PAYER 200
11.3.1.1 Expansion of value-based care and automated claims management supporting market growth 200
11.3.2 PRIVATE PAYER 201
11.3.2.1 Private payers are accelerating investments in AI-enabled claims and member management solutions 201
11.4 LIFE SCIENCE INDUSTRY 201
11.4.1 STRATEGIC AI PARTNERSHIPS AND DIGITAL RESEARCH PLATFORMS FUEL MARKET GROWTH 201

12 HEALTHCARE IT MARKET, BY REGION 203
12.1 INTRODUCTION 204
12.2 NORTH AMERICA 204
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 205
12.2.2 US 206
12.2.2.1 Strategic collaborations and connected care expansion to fuel US healthcare IT market 206
12.2.3 CANADA 215
12.2.3.1 Canada accelerates healthcare IT modernization through interoperability initiatives 215
13 COMPETITIVE LANDSCAPE 227
13.1 OVERVIEW 227
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 227
13.3 REVENUE ANALYSIS 229
13.4 MARKET SHARE ANALYSIS 230
13.5 BRAND COMPARISON 233
13.6 COMPANY VALUATION & FINANCIAL METRICS 234
13.6.1 FINANCIAL METRICS 234
13.6.2 COMPANY VALUATION 234
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 235
13.7.1 STARS 235
13.7.2 EMERGING LEADERS 235
13.7.3 PERVASIVE PLAYERS 235
13.7.4 PARTICIPANTS 235
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 237
13.7.5.1 Company footprint 237
13.7.5.2 Regional footprint 238
13.7.5.3 Solution and service footprint 239
13.7.5.4 Component footprint 240
13.7.5.5 End user footprint 241
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 242
13.8.1 PROGRESSIVE COMPANIES 242
13.8.2 RESPONSIVE COMPANIES 242
13.8.3 DYNAMIC COMPANIES 242
13.8.4 STARTING BLOCKS 242
13.8.5 COMPETITIVE BENCHMARKING 244
13.8.5.1 Detailed list of key startups/SMEs 244
13.8.5.2 Competitive benchmarking of key startups/SMEs 244
13.9 COMPETITIVE SCENARIO 245
13.9.1 PRODUCT LAUNCHES & APPROVALS 245
13.9.2 DEALS 246
14 COMPANY PROFILES 248
14.1 KEY PLAYERS 248
14.1.1 OPTUM, INC. 248
14.1.1.1 Business overview 248
14.1.1.2 Products & services offered 249
14.1.1.3 Recent developments 251
14.1.1.3.1 Product launches & approvals 251
14.1.1.3.2 Deals 252
14.1.1.4 MnM view 254
14.1.1.4.1 Key strengths 254
14.1.1.4.2 Strategic choices 254
14.1.1.4.3 Weaknesses & competitive threats 254
14.1.2 COGNIZANT 255
14.1.2.1 Business overview 255
14.1.2.2 Products & services offered 256
14.1.2.3 Recent developments 258
14.1.2.3.1 Product launches & approvals 258
14.1.2.3.2 Deals 259
14.1.2.4 MnM view 261
14.1.2.4.1 Right to win 261
14.1.2.4.2 Strategic choices 261
14.1.2.4.3 Weaknesses & competitive threats 261
14.1.3 KONINKLIJKE PHILIPS N.V. 262
14.1.3.1 Business overview 262
14.1.3.2 Products offered 264
14.1.3.3 Recent developments 266
14.1.3.3.1 Product launches & approvals 266
14.1.3.3.2 Deals 267
14.1.3.4 MnM view 269
14.1.3.4.1 Right to win 269
14.1.3.4.2 Strategic choices made 269
14.1.3.4.3 Weaknesses and competitive threats 269
14.1.4 DELL INC. 270
14.1.4.1 Business overview 270
14.1.4.2 Products offered 271
14.1.4.3 Recent developments 272
14.1.4.3.1 Product launches & approvals 272
14.1.4.3.2 Deals 273
14.1.4.4 MnM view 274
14.1.4.4.1 Right to win 274
14.1.4.4.2 Strategic choices 274
14.1.4.4.3 Weaknesses and competitive threats 274
14.1.5 GE HEALTHCARE 275
14.1.5.1 Business overview 275
14.1.5.2 Products offered 276
14.1.5.3 Recent developments 278
14.1.5.3.1 Product launches & approvals 278
14.1.5.3.2 Deals 279
14.1.5.4 MnM view 280
14.1.5.4.1 Right to win 280
14.1.5.4.2 Strategic choices 280
14.1.5.4.3 Weaknesses and competitive threats 281
14.1.6 ORACLE 282
14.1.6.1 Business overview 282
14.1.6.2 Products offered 283
14.1.6.3 Recent developments 284
14.1.6.3.1 Product launches & approvals 284
14.1.6.3.2 Deals 285
14.1.7 WIPRO 287
14.1.7.1 Business overview 287
14.1.7.2 Products offered 288
14.1.7.3 Recent developments 290
14.1.7.3.1 Product launches & approvals 290
14.1.7.3.2 Deals 290
14.1.8 ECLINICALWORKS 292
14.1.8.1 Business overview 292
14.1.8.2 Products offered 292
14.1.8.3 Recent developments 293
14.1.8.3.1 Product launches & approvals 293
14.1.8.3.2 Deals 295
14.1.9 SAS INSTITUTE INC. 297
14.1.9.1 Business overview 297
14.1.9.2 Products offered 298
14.1.9.3 Recent developments 298
14.1.9.3.1 Product launches & approvals 298
14.1.9.3.2 Deals 299
14.1.10 INOVALON 300
14.1.10.1 Business overview 300
14.1.10.2 Products offered 301
14.1.10.3 Recent developments 302
14.1.10.3.1 Product launches & approvals 302
14.1.10.3.2 Deals 303

14.1.11 INFOR (KOCH INDUSTRIES) 304
14.1.11.1 Business overview 304
14.1.11.2 Products offered 304
14.1.11.3 Recent developments 305
14.1.11.3.1 Product launches & approvals 305
14.1.11.3.2 Deals 306
14.1.12 CONIFER HEALTH SOLUTIONS, LLC. 307
14.1.12.1 Business overview 307
14.1.12.2 Products offered 307
14.1.12.3 Recent developments 308
14.1.12.3.1 Deals 308
14.1.13 NUANCE COMMUNICATIONS, INC.(MICROSOFT) 310
14.1.13.1 Business overview 310
14.1.13.2 Products offered 311
14.1.13.3 Recent developments 312
14.1.13.3.1 Product launches & approvals 312
14.1.13.3.2 Deals 313
14.1.14 SOLVENTUM 314
14.1.14.1 Business overview 314
14.1.14.2 Products offered 315
14.1.14.3 Recent developments 317
14.1.14.3.1 Product launches & approvals 317
14.1.14.3.2 Deals 318
14.1.15 MERATIVE 319
14.1.15.1 Business overview 319
14.1.15.2 Products offered 319
14.1.15.3 Recent developments 320
14.1.15.3.1 Product launches & approvals 320
14.1.15.3.2 Deals 321
14.1.16 EPIC SYSTEMS CORPORATION 322
14.1.16.1 Business overview 322
14.1.16.2 Products offered 322
14.1.16.3 Recent developments 324
14.1.16.3.1 Product launches & approvals 324
14.1.16.3.2 Deals 325
14.1.17 INTERSYSTEMS CORPORATION 326
14.1.17.1 Business overview 326
14.1.17.2 Products offered 326
14.1.17.3 Recent developments 328
14.1.17.3.1 Product launches & approvals 328
14.1.17.3.2 Deals 329

14.1.18 VERADIGM LLC 330
14.1.18.1 Business overview 330
14.1.18.2 Products offered 331
14.1.18.3 Recent developments 333
14.1.18.3.1 Product launches & approvals 333
14.1.18.3.2 Deals 333
14.1.19 SALESFORCE, INC. 335
14.1.19.1 Business overview 335
14.1.19.2 Products offered 336
14.1.19.3 Recent developments 337
14.1.19.3.1 Product launches & approvals 337
14.1.19.3.2 Deals 337
14.1.20 CITIUSTECH INC 339
14.1.20.1 Business overview 339
14.1.20.2 Products offered 339
14.1.20.3 Recent developments 340
14.1.20.3.1 Product launches & approvals 340
14.1.20.3.2 Deals 341
14.2 OTHER PLAYERS 342
14.2.1 CONDUENT, INC. 342
14.2.2 CARESTREAM HEALTH. 343
14.2.3 PRACTICE FUSION, INC. 344
14.2.4 POINTCLICKCARE 345
14.2.5 INNOVACCER 346
14.2.6 MEDEANALYTICS, INC. 347
14.2.7 MEDECISION 348
14.2.8 SUKI AI, INC 349
14.2.9 CHARTIS 350
14.2.10 CLEARWAVE CORPORATION 351
15 RESEARCH METHODOLOGY 352
15.1 RESEARCH APPROACH 352
15.1.1 SECONDARY RESEARCH 353
15.1.1.1 Key data from secondary sources 354
15.1.2 PRIMARY RESEARCH 354
15.1.2.1 Primary sources 355
15.1.2.2 Key data from primary sources 356
15.1.2.3 Breakdown of primaries 356
15.1.2.4 Insights from primary experts 357
15.2 RESEARCH METHODOLOGY DESIGN 357
15.3 MARKET SIZE ESTIMATION 359
15.4 MARKET BREAKDOWN & DATA TRIANGULATION 363
15.5 MARKET SHARE ESTIMATION 363
15.6 STUDY ASSUMPTIONS 364
15.7 RESEARCH LIMITATIONS 364
15.7.1 METHODOLOGY-RELATED LIMITATIONS 364
15.8 RISK ASSESSMENT 364
16 APPENDIX 365
16.1 DISCUSSION GUIDE 365
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 370
16.3 CUSTOMIZATION OPTIONS 372
16.4 RELATED REPORTS 372
16.5 AUTHOR DETAILS 373

LIST OF TABLES

TABLE 1 EXCHANGE RATES, 2022–2025 36
TABLE 2 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES, 2025 60
TABLE 3 NORTH AMERICA HEALTHCARE IT: PORTER’S FIVE FORCES ANALYSIS 66
TABLE 4 NORTH AMERICA HEALTHCARE IT MARKET: ROLE IN ECOSYSTEM 73
TABLE 5 INDICATIVE PRICE OF CLINICAL DECISION SUPPORT SYSTEMS, BY PRODUCT, 2025 74
TABLE 6 INDICATIVE PRICE OF HCIT INTEGRATION SOLUTIONS, BY SUBSCRIPTION TYPE 75
TABLE 7 INDICATIVE PRICE OF LABORATORY INFORMATION SYSTEMS 77
TABLE 8 INDICATIVE PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT 78
TABLE 9 INDICATIVE PRICE OF HEALTHCARE IT SOLUTIONS, BY COUNTRY 79
TABLE 10 HEALTHCARE IT: KEY CONFERENCES & EVENTS, 2026–2027 79
TABLE 11 REVOLUTIONIZING PATIENT ENGAGEMENT WITH AI 82
TABLE 12 ECOA FOR PHASE I ONCOLOGY STUDIES 83
TABLE 13 REAL-TIME ANALYTICS AND RATER TRAINING FOR PHASE II DERMATOLOGY TRIAL 84
TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES 86
TABLE 15 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR NORTH AMERICA HEALTHCARE IT MARKET 97
TABLE 16 NORTH AMERICA HEALTHCARE IT MARKET: LIST OF PATENTS/PATENT APPLICATIONS 99
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110
TABLE 18 REGULATORY SCENARIO IN NORTH AMERICA 111
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 114
TABLE 20 KEY BUYING CRITERIA, BY END USER 116
TABLE 21 UNMET NEEDS IN NORTH AMERICA HEALTHCARE IT MARKET 118
TABLE 22 END USER EXPECTATIONS IN NORTH AMERICA HEALTHCARE IT MARKET 118
TABLE 23 NORTH AMERICA HEALTHCARE IT MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 121
TABLE 24 NORTH AMERICA HEALTHCARE IT MARKET FOR SERVICES, BY REGION,
2024–2031 (USD MILLION) 122
TABLE 25 NORTH AMERICA HEALTHCARE IT MARKET FOR SOFTWARE, BY REGION,
2024–2031 (USD MILLION) 123
TABLE 26 HEALTHCARE IT MARKET FOR HARDWARE, BY REGION,
2024–2031 (USD MILLION) 124
TABLE 27 HEALTHCARE IT MARKET, BY SOLUTION & SERVICE, 2024–2031 (USD MILLION) 126
TABLE 28 HEALTHCARE IT MARKET BY HEALTHCARE PROVIDER SOLUTIONS,
2024–2031 (USD MILLION) 127
TABLE 29 HEALTHCARE IT MARKET FOR HEALTHCARE PROVIDER SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 30 HEALTHCARE IT MARKET BY CLINICAL HEALTHCARE IT SOLUTIONS,
2024–2031 (USD MILLION) 128
TABLE 31 HEALTHCARE IT MARKET FOR CLINICAL HCIT SOLUTIONS, BY COUNTRY,
2024–2031 (USD MILLION) 129
TABLE 32 HEALTHCARE IT MARKET FOR ELECTRONIC HEALTH RECORDS, BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 33 HEALTHCARE IT MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 34 HEALTHCARE IT MARKET BY SPECIALTY INFORMATION MANAGEMENT,
2024–2031 (USD MILLION) 132
TABLE 35 HEALTHCARE IT MARKET FOR SPECIALTY INFORMATION MANAGEMENT,
BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 36 HEALTHCARE IT MARKET FOR ONCOLOGY INFORMATION SYSTEM, BY COUNTRY, 2024–2031 (USD MILLION) 133
TABLE 37 HEALTHCARE IT MARKET FOR CARDIOLOGY INFORMATION SYSTEM, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 38 HEALTHCARE IT MARKET FOR OTHER INFORMATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 39 HEALTHCARE IT MARKET FOR PACS & VNA, BY COUNTRY,
2024–2031 (USD MILLION) 136
TABLE 40 HEALTHCARE IT MARKET FOR MHEALTH APPLICATION, BY COUNTRY,
2024–2031 (USD MILLION) 137
TABLE 41 HEALTHCARE IT MARKET FOR HCIT INTEGRATION, BY COUNTRY,
2024–2031 (USD MILLION) 138
TABLE 42 HEALTHCARE IT MARKET FOR TELEHEALTH SOLUTION, BY COUNTRY,
2024–2031 (USD MILLION) 138
TABLE 43 HEALTHCARE IT MARKET FOR MEDICAL IMAGE ANALYSIS, BY COUNTRY,
2024–2031 (USD MILLION) 139
TABLE 44 HEALTHCARE IT MARKET FOR LABORATORY INFORMATION SYSTEMS,
BY COUNTRY, 2024–2031 (USD MILLION) 140
TABLE 45 HEALTHCARE IT MARKET FOR PRACTICE MANAGEMENT SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 46 HEALTHCARE IT MARKET FOR CLINICAL DECISION SUPPORT SYSTEM,
BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 47 HEALTHCARE IT MARKET FOR E-PRESCRIBING SOLUTION, BY COUNTRY,
2024–2031 (USD MILLION) 142
TABLE 48 HEALTHCARE IT MARKET FOR RADIOLOGY INFORMATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 49 HEALTHCARE IT MARKET FOR COMPUTERIZED PHYSICIAN ORDER ENTRY,
BY COUNTRY, 2024–2031 (USD MILLION) 144
TABLE 50 HEALTHCARE IT MARKET FOR PATIENT REGISTRY SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 51 HEALTHCARE IT MARKET FOR INFECTION SURVEILLANCE, BY COUNTRY,
2024–2031 (USD MILLION) 146
TABLE 52 HEALTHCARE IT MARKET FOR RADIATION DOSE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 53 HEALTHCARE IT MARKET BY NON-CLINICAL HEALTHCARE IT SOLUTIONS,
2024–2031 (USD MILLION) 148
TABLE 54 HEALTHCARE IT MARKET FOR NON-CLINICAL HEALTHCARE IT SOLUTIONS,
BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 55 HEALTHCARE IT MARKET FOR HEALTHCARE ASSET MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 56 HEALTHCARE IT MARKET BY REVENUE CYCLE MANAGEMENT,
2024–2031 (USD MILLION) 151
TABLE 57 HEALTHCARE IT MARKET FOR REVENUE CYCLE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 58 HEALTHCARE IT MARKET FOR FRONT END RCM SOLUTIONS, BY COUNTRY,
2024–2031 (USD MILLION) 152
TABLE 59 HEALTHCARE IT MARKET FOR MID-RCM SOLUTIONS, BY COUNTRY,
2024–2031 (USD MILLION) 153
TABLE 60 HEALTHCARE IT MARKET FOR BACK END-RCM SOLUTIONS, BY COUNTRY,
2024–2031 (USD MILLION) 154
TABLE 61 HEALTHCARE IT MARKET BY HEALTHCARE ANALYTICS, 2024–2031 (USD MILLION) 155
TABLE 62 HEALTHCARE IT MARKET FOR HEALTHCARE ANALYTICS, BY COUNTRY,
2024–2031 (USD MILLION) 155
TABLE 63 HEALTHCARE IT MARKET FOR CLINICAL ANALYTICS, BY COUNTRY,
2024–2031 (USD MILLION) 156
TABLE 64 HEALTHCARE IT MARKET FOR FINANCIAL ANALYTICS, BY COUNTRY,
2024–2031 (USD MILLION) 157
TABLE 65 HEALTHCARE IT MARKET FOR OPERATIONAL AND ADMINISTRATIVE ANALYTICS,
BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 66 HEALTHCARE IT MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT,
BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 67 HEALTHCARE IT MARKET FOR PHARMACY INFORMATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 68 HEALTHCARE IT MARKET FOR HEALTHCARE INTEROPERABILITY, BY COUNTRY, 2024–2031 (USD MILLION) 160
TABLE 69 HEALTHCARE IT MARKET FOR HEALTHCARE QUALITY MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 161
TABLE 70 HEALTHCARE IT MARKET BY SUPPLY CHAIN MANAGEMENT,
2024–2031 (USD MILLION) 162
TABLE 71 HEALTHCARE IT MARKET FOR SUPPLY CHAIN MANAGEMENT, BY COUNTRY,
2024–2031 (USD MILLION) 162
TABLE 72 HEALTHCARE IT MARKET FOR PROCUREMENT MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 73 HEALTHCARE IT MARKET FOR INVENTORY MANAGEMENT, BY COUNTRY,
2024–2031 (USD MILLION) 163
TABLE 74 HEALTHCARE IT MARKET BY MEDICATION MANAGEMENT,
2024–2031 (USD MILLION) 164
TABLE 75 HEALTHCARE IT MARKET FOR MEDICATION MANAGEMENT, BY COUNTRY,
2024–2031 (USD MILLION) 165
TABLE 76 HEALTHCARE IT MARKET FOR ELECTRONIC MEDICATION ADMINISTRATION,
BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 77 HEALTHCARE IT MARKET FOR BARCODE MEDICATION ADMINISTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 78 HEALTHCARE IT MARKET FOR MEDICATION INVENTORY MANAGEMENT SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 167
TABLE 79 HEALTHCARE IT MARKET FOR MEDICATION ASSURANCE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 80 HEALTHCARE IT MARKET FOR WORKFORCE MANAGEMENT, BY COUNTRY,
2024–2031 (USD MILLION) 169
TABLE 81 HEALTHCARE IT MARKET FOR HEALTHCARE INFORMATION EXCHANGE,
BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 82 HEALTHCARE IT MARKET FOR MEDICAL DOCUMENT MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 170
TABLE 83 HEALTHCARE IT MARKET BY HEALTHCARE PAYER SOLUTIONS,
2024–2031 (USD MILLION) 171
TABLE 84 HEALTHCARE IT MARKET FOR HEALTHCARE PAYER SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 85 HEALTHCARE IT MARKET FOR CLAIMS MANAGEMENT, BY COUNTRY,
2024–2031 (USD MILLION) 172
TABLE 86 HEALTHCARE IT MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 87 HEALTHCARE IT MARKET FOR PHARMACY AUDIT & ANALYSIS, BY COUNTRY,
2024–2031 (USD MILLION) 174
TABLE 88 HEALTHCARE IT MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT,
BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 89 HEALTHCARE IT MARKET FOR FRAUD ANALYTICS SOLUTIONS, BY COUNTRY,
2024–2031 (USD MILLION) 176
TABLE 90 HEALTHCARE IT MARKET FOR PROVIDER NETWORK MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 91 HEALTHCARE IT MARKET BY HEALTHCARE IT OUTSOURCING SERVICES,
2024–2031 (USD MILLION) 177
TABLE 92 HEALTHCARE IT MARKET FOR HEALTHCARE IT OUTSOURCING SERVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 93 HEALTHCARE IT MARKET FOR IT INFRASTRUCTURE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 94 HEALTHCARE IT MARKET BY PAYER HEALTHCARE IT OUTSOURCING SERVICES, 2024–2031 (USD MILLION) 179
TABLE 95 HEALTHCARE IT MARKET FOR PAYER HEALTHCARE IT OUTSOURCING SERVICES,
BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 96 HEALTHCARE IT MARKET FOR CLAIMS MANAGEMENT, BY COUNTRY,
2024–2031 (USD MILLION) 180
TABLE 97 HEALTHCARE IT MARKET FOR PROVIDER NETWORK MANAGEMENT
(OUTSOURCING SERVICES), BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 98 HEALTHCARE IT MARKET FOR BILLING & ACCOUNTS MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 99 HEALTHCARE IT MARKET FOR FRAUD ANALYTICS, BY COUNTRY,
2024–2031 (USD MILLION) 183
TABLE 100 HEALTHCARE IT MARKET FOR OTHER PAYER HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 101 HEALTHCARE IT MARKET BY PROVIDER HEALTHCARE IT OUTSOURCING SERVICES, 2024–2031 (USD MILLION) 184
TABLE 102 HEALTHCARE IT MARKET FOR PROVIDER HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 184
TABLE 103 HEALTHCARE IT MARKET FOR REVENUE CYCLE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 104 HEALTHCARE IT MARKET FOR MEDICAL DOCUMENTS MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 105 HEALTHCARE IT MARKET FOR LABORATORY INFORMATION MANAGEMENT,
BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 106 HEALTHCARE IT MARKET FOR OTHER PROVIDER HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 107 HEALTHCARE IT MARKET BY OPERATIONAL HEALTHCARE IT OUTSOURCING SERVICES, 2024–2031 (USD MILLION) 188
TABLE 108 HEALTHCARE IT MARKET FOR OPERATIONAL HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 109 HEALTHCARE IT MARKET FOR SUPPLY CHAIN MANAGEMENT, BY COUNTRY,
2024–2031 (USD MILLION) 189
TABLE 110 HEALTHCARE IT MARKET FOR BUSINESS PROCESS MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 190
TABLE 111 HEALTHCARE IT MARKET FOR OTHER OPERATIONAL HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 112 HEALTHCARE IT MARKET, BY END USER, 2024–2031 (USD MILLION) 193
TABLE 113 HEALTHCARE IT MARKET BY HEALTHCARE PROVIDERS,
2024–2031 (USD MILLION) 194
TABLE 114 HEALTHCARE IT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY,
2024–2031 (USD MILLION) 194
TABLE 115 HEALTHCARE IT MARKET FOR HOSPITALS, BY COUNTRY,
2024–2031 (USD MILLION) 195
TABLE 116 HEALTHCARE IT MARKET FOR AMBULATORY CARE CENTERS (OUTPATIENT SETTING), BY COUNTRY, 2024–2031 (USD MILLION) 196
TABLE 117 HEALTHCARE IT MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES, BY COUNTRY, 2024–2031 (USD MILLION) 196
TABLE 118 HEALTHCARE IT MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 197
TABLE 119 HEALTHCARE IT MARKET FOR PHARMACIES, BY COUNTRY,
2024–2031 (USD MILLION) 198
TABLE 120 HEALTHCARE IT MARKET BY HEALTHCARE PAYERS, 2024–2031 (USD MILLION) 199
TABLE 121 HEALTHCARE IT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY,
2024–2031 (USD MILLION) 199
TABLE 122 HEALTHCARE IT MARKET FOR PUBLIC PAYER, BY COUNTRY,
2024–2031 (USD MILLION) 200
TABLE 123 HEALTHCARE IT MARKET FOR PRIVATE PAYER, BY COUNTRY,
2024–2031 (USD MILLION) 201
TABLE 124 HEALTHCARE IT MARKET FOR LIFE SCIENCE INDUSTRY, BY COUNTRY,
2024–2031 (USD MILLION) 202
TABLE 125 NORTH AMERICA: HEALTHCARE IT MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 206
TABLE 126 US: HEALTHCARE IT MARKET, BY SOLUTION & SERVICE,
2024–2031 (USD MILLION) 207
TABLE 127 US: HEALTHCARE PROVIDER SOLUTIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 208
TABLE 128 US: CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 208
TABLE 129 US: NON-CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 209
TABLE 130 US: SPECIALTY INFORMATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 131 US: RCM SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 210
TABLE 132 US: MEDICATION MANAGEMENT SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 133 US: SCM SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 211
TABLE 134 US: HEALTHCARE ANALYTICS SOLUTIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 135 US: HEALTHCARE PAYER SOLUTIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 212
TABLE 136 US: HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 212
TABLE 137 US: PROVIDER HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 138 US: PAYER HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 213
TABLE 139 US: OPERATIONAL HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 140 US: HEALTHCARE IT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 214
TABLE 141 US: HEALTHCARE IT MARKET, BY END USER, 2024–2031 (USD MILLION) 214
TABLE 142 US: HEALTHCARE IT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 143 US: HEALTHCARE IT MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 144 CANADA: HEALTHCARE IT MARKET, BY SOLUTION & SERVICE,
2024–2031 (USD MILLION) 217
TABLE 145 CANADA: HEALTHCARE PROVIDER SOLUTIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 217
TABLE 146 CANADA: CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 218
TABLE 147 CANADA: NON-CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 148 CANADA: SPECIALTY INFORMATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 149 CANADA: RCM SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 220
TABLE 150 CANADA: MEDICATION MANAGEMENT SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 221
TABLE 151 CANADA: SCM SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 152 CANADA: HEALTHCARE ANALYTICS SOLUTIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 222
TABLE 153 CANADA: HEALTHCARE PAYER SOLUTIONS MARKET, BY TYPE,
2024–2031 (USD MILLION) 222
TABLE 154 CANADA: HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 223
TABLE 155 CANADA: PROVIDER HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 156 CANADA: PAYER HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 157 CANADA: OPERATIONAL HEALTHCARE IT OUTSOURCING SERVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 158 CANADA: HEALTHCARE IT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 225
TABLE 159 CANADA: HEALTHCARE IT MARKET, BY END USER, 2024–2031 (USD MILLION) 225
TABLE 160 CANADA: HEALTHCARE IT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2024–2031 (USD MILLION) 225
TABLE 161 CANADA: HEALTHCARE IT MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 226
TABLE 162 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS,
JANUARY 2023–MAY 2026 227
TABLE 163 NORTH AMERICA HEALTHCARE IT MARKET: DEGREE OF COMPETITION 231
TABLE 164 NORTH AMERICA HEALTHCARE IT MARKET: COUNTRY FOOTPRINT
(20 COMPANIES), 2025 238
TABLE 165 NORTH AMERICA HEALTHCARE IT MARKET: SOLUTION AND SERVICE FOOTPRINT (20 COMPANIES), 2025 239
TABLE 166 NORTH AMERICA HEALTHCARE IT MARKET: COMPONENT FOOTPRINT
(20 COMPANIES), 2025 240
TABLE 167 NORTH AMERICA HEALTHCARE IT MARKET: END USER FOOTPRINT
(20 COMPANIES), 2025 241
TABLE 168 NORTH AMERICA HEALTHCARE IT MARKET: DETAILED LIST OF
KEY STARTUPS/SMES 244
TABLE 169 NORTH AMERICA HEALTHCARE IT MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 244
TABLE 170 NORTH AMERICA HEALTHCARE IT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 245
TABLE 171 NORTH AMERICA HEALTHCARE IT MARKET: DEALS, JANUARY 2023–MAY 2026 246
TABLE 172 OPTUM, INC.: COMPANY OVERVIEW 248
TABLE 173 OPTUM, INC.: PRODUCTS & SERVICES OFFERED 249
TABLE 174 OPTUM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 251
TABLE 175 OPTUM, INC.: DEALS, JANUARY 2023–MAY 2026 252
TABLE 176 COGNIZANT: COMPANY OVERVIEW 255
TABLE 177 COGNIZANT: PRODUCTS & SERVICES OFFERED 256
TABLE 178 COGNIZANT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 258
TABLE 179 COGNIZANT: DEALS, JANUARY 2023–MAY 2026 259
TABLE 180 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 262
TABLE 181 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 264
TABLE 182 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–MAY 2026 266
TABLE 183 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–MAY 2026 267
TABLE 184 DELL INC.: COMPANY OVERVIEW 270
TABLE 185 DELL INC.: PRODUCTS OFFERED 271
TABLE 186 DELL INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 272
TABLE 187 DELL INC.: DEALS, JANUARY 2023–MAY 2026 273
TABLE 188 GE HEALTHCARE: COMPANY OVERVIEW 275
TABLE 189 GE HEALTHCARE: PRODUCTS OFFERED 276
TABLE 190 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 278
TABLE 191 GE HEALTHCARE: DEALS, JANUARY 2023–MAY 2026 279
TABLE 192 ORACLE: COMPANY OVERVIEW 282
TABLE 193 ORACLE: PRODUCTS OFFERED 283
TABLE 194 ORACLE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023 TO MAY 2026 284
TABLE 195 ORACLE: DEALS, JANUARY 2023–MAY 2026 285
TABLE 196 WIPRO: COMPANY OVERVIEW 287
TABLE 197 WIPRO: PRODUCTS OFFERED 288
TABLE 198 WIPRO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 290
TABLE 199 WIPRO: DEALS, JANUARY 2023–MAY 2026 290
TABLE 200 ECLINICALWORKS: COMPANY OVERVIEW 292
TABLE 201 ECLINICALWORKS: PRODUCTS OFFERED 292
TABLE 202 ECLINICALWORKS: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–MAY 2026 293
TABLE 203 ECLINICALWORKS: DEALS, JANUARY 2023–MAY 2026 295
TABLE 204 SAS INSTITUTE INC.: COMPANY OVERVIEW 297
TABLE 205 SAS INSTITUTE INC.: PRODUCTS OFFERED 298
TABLE 206 SAS INSTITUTE INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–MAY 2026 298
TABLE 207 SAS INSTITUTE INC.: DEALS, JANUARY 2023–MAY 2026 299
TABLE 208 INOVALON: COMPANY OVERVIEW 300
TABLE 209 INOVALON: PRODUCTS OFFERED 301
TABLE 210 INOVALON: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 302
TABLE 211 INOVALON: DEALS, JANUARY 2023–MAY 2026 303
TABLE 212 INFOR: COMPANY OVERVIEW 304
TABLE 213 INFOR: PRODUCTS OFFERED 304
TABLE 214 INFOR: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 305
TABLE 215 INFOR: DEALS, JANUARY 2023–MAY 2026 306
TABLE 216 CONIFER HEALTH SOLUTIONS, LLC.: COMPANY OVERVIEW 307
TABLE 217 CONIFER HEALTH SOLUTIONS, LLC.: PRODUCTS OFFERED 307
TABLE 218 CONIFER HEALTH SOLUTIONS, LLC.: DEALS, JANUARY 2023–MAY 2026 308
TABLE 219 NUANCE COMMUNICATIONS, INC.(MICROSOFT): COMPANY OVERVIEW 310
TABLE 220 NUANCE COMMUNICATIONS, INC. (MICROSOFT): PRODUCTS OFFERED 311
TABLE 221 NUANCE COMMUNICATIONS, INC.(MICROSOFT): PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 312
TABLE 222 NUANCE COMMUNICATIONS, INC. (MICROSOFT): DEALS,
JANUARY 2023–MAY 2026 313
TABLE 223 SOLVENTUM: COMPANY OVERVIEW 314
TABLE 224 SOLVENTUM: PRODUCTS OFFERED 315
TABLE 225 SOLVENTUM: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 317
TABLE 226 SOLVENTUM: DEALS, JANUARY 2023–MAY 2026 318
TABLE 227 MERATIVE: COMPANY OVERVIEW 319
TABLE 228 MERATIVE: PRODUCTS OFFERED 319
TABLE 229 MERATIVE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 320
TABLE 230 MERATIVE: DEALS, JANUARY 2023–MAY 2026 321
TABLE 231 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 322
TABLE 232 EPIC SYSTEMS CORPORATION.: PRODUCTS OFFERED 322
TABLE 233 EPIC SYSTEMS CORPORATION.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–MAY 2026 324
TABLE 234 EPIC SYSTEMS CORPORATION.: DEALS, JANUARY 2023–MAY 2026 325
TABLE 235 INTERSYSTEMS CORPORATION: COMPANY OVERVIEW 326
TABLE 236 INTERSYSTEMS CORPORATION: PRODUCTS OFFERED 326
TABLE 237 INTERSYSTEMS CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–MAY 2026 328
TABLE 238 INTERSYSTEMS CORPORATION: DEALS, JANUARY 2023–MAY 2026 329
TABLE 239 VERADIGM LLC: COMPANY OVERVIEW 330
TABLE 240 VERADIGM LLC: PRODUCTS OFFERED 331
TABLE 241 VERADIGM LLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 333
TABLE 242 VERADIGM LLC: DEALS, JANUARY 2023 TO MAY 2026 333
TABLE 243 SALESFORCE, INC.: COMPANY OVERVIEW 335
TABLE 244 SALESFORCE, INC.: PRODUCTS OFFERED 336
TABLE 245 SALESFORCE, INC: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–MAY 2026 337
TABLE 246 SALESFORCE, INC.: DEALS, JANUARY 2023–MAY 2026 337
TABLE 247 CITIUSTECH INC: COMPANY OVERVIEW 339
TABLE 248 CITIUSTECH INC: PRODUCTS OFFERED 339
TABLE 249 CITIUSTECH INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 340
TABLE 250 CITIUSTECH INC: DEALS, JANUARY 2023–MAY 2026 341
TABLE 251 RISK ASSESSMENT: NORTH AMERICA HEALTHCARE IT MARKET 364

LIST OF FIGURES

FIGURE 1 NORTH AMERICA HEALTHCARE IT MARKET SEGMENTATION 34
FIGURE 2 MARKET SCENARIO 39
FIGURE 3 NORTH AMERICA HEALTHCARE IT MARKET, 2024–2031 (USD MILLION) 39
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NORTH AMERICA HEALTHCARE IT MARKET, 2023–2026 40
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF NORTH AMERICA HEALTHCARE IT MARKET 41
FIGURE 6 HIGH-GROWTH SEGMENTS 42
FIGURE 7 US TO REGISTER HIGHEST GROWTH, IN TERMS OF VALUE, DURING FORECAST PERIOD 43
FIGURE 8 RISING HEALTHCARE DIGITIZATION TO DRIVE GROWTH IN NORTH AMERICA HEALTHCARE IT MARKET 45
FIGURE 9 SERVICES IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 46
FIGURE 10 US TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 46
FIGURE 11 NORTH AMERICA HEALTHCARE IT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
FIGURE 12 HEALTHCARE SECURITY BREACHES: REPORTING ENTITY, 2009–2026 58
FIGURE 13 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES, 2021–2025 59
FIGURE 14 NORTH AMERICA HEALTHCARE IT MARKET: PORTER’S FIVE FORCES ANALYSIS 65
FIGURE 15 VALUE CHAIN ANALYSIS 70
FIGURE 16 ECOSYSTEM ANALYSIS 73
FIGURE 17 REVENUE SHIFT IN NORTH AMERICA HEALTHCARE IT MARKET 81
FIGURE 18 RECENT FUNDING OF PLAYERS IN NORTH AMERICA HEALTHCARE IT MARKET 82
FIGURE 19 PATENT PUBLICATION TRENDS IN NORTH AMERICA HEALTHCARE IT MARKET, 2015–2025 97
FIGURE 20 JURISDICTION AND TOP APPLICANT ANALYSIS FOR NORTH AMERICA HEALTHCARE IT MARKET 97
FIGURE 21 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE IT MARKET (JANUARY 2015 TO DECEMBER 2025) 98
FIGURE 22 MARKET POTENTIAL OF GENERATIVE AI IN ENHANCING HEALTHCARE IT ACROSS INDUSTRIES 102
FIGURE 23 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 105
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 114
FIGURE 25 KEY BUYING CRITERIA, BY END USER 115
FIGURE 26 NORTH AMERICA: HEALTHCARE IT MARKET SNAPSHOT 205
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD MILLION) 230
FIGURE 28 NORTH AMERICA HEALTHCARE IT MARKET: MARKET SHARE ANALYSIS, 2025 231
FIGURE 29 NORTH AMERICA HEALTHCARE IT MARKET: BRAND COMPARATIVE ANALYSIS 233
FIGURE 30 EV/EBITDA OF KEY VENDORS 234
FIGURE 31 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK
BETA OF KEY VENDORS 234
FIGURE 32 NORTH AMERICA HEALTHCARE IT MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 236
FIGURE 33 NORTH AMERICA HEALTHCARE IT MARKET: COMPANY FOOTPRINT
(20 COMPANIES), 2025 237
FIGURE 34 NORTH AMERICA HEALTHCARE IT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 243
FIGURE 35 OPTUM, INC.: COMPANY SNAPSHOT (2025) 249
FIGURE 36 COGNIZANT: COMPANY SNAPSHOT (2025) 256
FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 263
FIGURE 38 DELL INC.: COMPANY SNAPSHOT (2025) 271
FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 276
FIGURE 40 ORACLE: COMPANY SNAPSHOT (2025) 283
FIGURE 41 WIPRO: COMPANY SNAPSHOT (2025) 288
FIGURE 42 NUANCE COMMUNICATIONS, INC. (MICROSOFT): COMPANY SNAPSHOT (2025) 311
FIGURE 43 SOLVENTUM: COMPANY SNAPSHOT (2025) 315
FIGURE 44 VERADIGM LLC: COMPANY SNAPSHOT (2022) 331
FIGURE 45 SALESFORCE, INC.: COMPANY SNAPSHOT (2025) 336
FIGURE 46 RESEARCH DESIGN 352
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 356
FIGURE 48 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 358
FIGURE 49 BOTTOM-UP APPROACH 359
FIGURE 50 TOP-DOWN APPROACH 360
FIGURE 51 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF HEALTHCARE IT INDUSTRY 361
FIGURE 52 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 362
FIGURE 53 DATA TRIANGULATION METHODOLOGY 363

---

---